Growth Metrics

Immuneering (IMRX) Non-Current Assets: 2020-2023

Historic Non-Current Assets for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $13.5 million.

  • Immuneering's Non-Current Assets changed negligibly% to $13.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $13.3 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $13.5 million for FY2023, which is 0.88% down from last year.
  • Per Immuneering's latest filing, its Non-Current Assets stood at $13.5 million for FY2023, which was down 0.88% from $13.6 million recorded in FY2022.
  • In the past 5 years, Immuneering's Non-Current Assets registered a high of $14.4 million during FY2021, and its lowest value of $691,799 during FY2020.
  • In the last 3 years, Immuneering's Non-Current Assets had a median value of $13.6 million in 2022 and averaged $13.8 million.
  • In the last 5 years, Immuneering's Non-Current Assets soared by 1,977.31% in 2021 and then dropped by 5.22% in 2022.
  • Immuneering's Non-Current Assets (Yearly) stood at $691,799 in 2020, then spiked by 1,977.31% to $14.4 million in 2021, then dropped by 5.22% to $13.6 million in 2022, then fell by 0.88% to $13.5 million in 2023.